Psychedelic research – Going global
- 1 December 2025
- journal article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 40 (1) , 5-9
Abstract
“Psychedelic research - Going global” is a Special Issue of the Journal of Psychopharmacology that has been compiled and published as a tribute to Dr. Roland R Griffiths in recognition of his pioneering and pivotal contribution to the field of psychedelic research. Dr. Griffiths was Professor in the Departments of Psychiatry and Neurosciences at Johns Hopkins University School of Medicine, and latterly, the founding director of the Center for Psychedelic and Consciousness Research. It is not an exaggeration to state that his discoveries, indefatigable support and advocacy laid the foundations of the global revival of psychedelic research. The issue commences with a tribute written by many of Dr. Griffiths’ scientific colleagues and friends. This homage summarises the fundamental contribution Dr. Griffiths made to research in many areas of neuropharmacology and psychiatry, in addition to his more recent published work on the neurobehavioural and therapeutic effects of the psychedelics. Other articles in this edition comprise a mix of commentaries, reviews, and original research and are divided under the headings of non-clinical, clinical, and strategic/regulatory. This Special Issue attracted contributions by experts from around the world, and as a compendium of knowledge, it is an invaluable resource that provides a clear perspective on the current status of research in the field. Dr. Griffiths was a scientist who maintained an open mind to ideas and knowledge from every source, and we are certain he would fully endorse the concept of Psychedelic research – Going global.Keywords
This publication has 13 references indexed in Scilit:
- Modification of natural tryptamines for the treatment of neuropsychiatric diseasesJournal of Psychopharmacology, 2025
- Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trialJournal of Psychopharmacology, 2025
- Pharmacological characterisation of psilocybin and 5-MeO-DMT discriminative cues in the rat and their translational value for identifying novel psychedelicsJournal of Psychopharmacology, 2025
- The development of translational tasks for preclinical psychedelic research in psychiatryJournal of Psychopharmacology, 2025
- Appraisal of the validity of preclinical investigations to predict the efficacy of psychedelic drugs as fast-acting antidepressantsJournal of Psychopharmacology, 2025
- A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapyJournal of Psychopharmacology, 2025
- Impact of psychedelics on craving in addiction: A systematic reviewJournal of Psychopharmacology, 2025
- Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysisJournal of Psychopharmacology, 2024
- Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trialsJournal of Psychopharmacology, 2024
- Mechanisms of psilocybin on the treatment of posttraumatic stress disorderJournal of Psychopharmacology, 2024